Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q1 FY25 results · Apr–Jun 2024

Krsnaa Diagnostics reported revenue from operations of ₹170.23 crore (up 22.0% from Q1 FY24) and net profit of ₹17.92 crore (up 22.4% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY25Q1 FY24YoYQ4 FY24QoQ
Revenue from operations170.23139.58+22.0%166.28+2.4%
Other income7.324.22+73.3%4.34+68.6%
Total income177.55143.80+23.5%170.62+4.1%
Profit before tax23.2017.89+29.7%22.61+2.6%
Net profit for the period17.9214.64+22.4%18.73−4.3%
EPS, basic (₹)5.554.66+19.1%5.80−4.3%
Net margin (%)10.510.511.3
Standalone · ₹ crore
ItemQ1 FY25Q1 FY24YoYQ4 FY24QoQ
Revenue from operations163.16132.28+23.3%159.33+2.4%
Other income7.324.22+73.3%4.34+68.7%
Total income170.48136.51+24.9%163.67+4.2%
Profit before tax23.5318.72+25.7%22.18+6.1%
Net profit for the period18.1815.25+19.2%18.42−1.3%
EPS, basic (₹)5.634.86+15.8%5.70−1.2%
Net margin (%)11.111.511.6
Consolidated
Filed with BSE
23 Aug 2024, 10:41 IST
Board meeting
06 Aug 2024
Period
01 Apr 2024 to 30 Jun 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
23 Aug 2024, 10:41 IST
Board meeting
06 Aug 2024
Period
01 Apr 2024 to 30 Jun 2024
Review status
Unaudited
Source
XBRL filing on BSE